Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Mike Sison

Wells Fargo · covers Basic Materials

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q1 (7 quarters).

Questions
54on tracked calls
Challenge rate
19%10 of 54 questions
Companies
11questioned at least once
Reporting periods
7with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 54 of 54 questions from 11 companies

DDDuPont11 questions · 6 reporting periods · 0 of 11 challenging
DD company page →

Calendar 2026 Q1

can you just talk about some of the underlying demand trends that are driving growth across the medical packaging and devices spaces

DemandRevenue GrowthTranscript · FY2026 Q1 →
Show response

Koch attributed healthcare growth to aging population and healthcare access megatrends. Med packaging exposure skews to higher-end Class 3 devices. Spectrum focused on cardiovascular and non-elective surgery applications.

when are you assuming the conflict in the Middle East resolved, if at all?

MacroeconomicCost PressureTranscript · FY2026 Q1 →
Show response

Franzen confirmed guidance assumes Middle East conflict and current oil/gas prices persist all year. Pricing actions already in place cover that scenario. Would take further actions if situation escalates.

Calendar 2025 Q4

is it still possible to change your industry designation

Competitive DynamicsTranscript · FY2025 Q4 →
Show response

Koch noted portfolio and performance clearly not a chemical company. Making progress on GICS reclassification but prioritizing execution. Continuing to push forward.

Any differences between nonres, res, and repair and model

DemandMacroeconomicTranscript · FY2025 Q4 →
Show response

Koch broke out: non-res up low single digits, repair & remodel up low single digits, offset by resi down low-to-mid single digits, netting to flat overall Shelter.

Calendar 2025 Q3

if it doesn't change it stays in chemicals, why do you think that is

Competitive DynamicsTranscript · FY2025 Q3 →
Show response

Franzen stated unequivocally that no specialty chemical peers are comparable, pointing to multi-industrial peers as the right benchmark regardless of GICS outcome.

Calendar 2025 Q2

Can you remind us kind of where we're at in terms of how much the portfolio is in advanced nodes and how much AI will continue to drive the growth

Cloud & AIRevenue GrowthTranscript · FY2025 Q2 →
Show response

Kemp sized advanced nodes at 35% of Semi (vs 20% industry), AI/data center at 15% of total portfolio growing above 20% in Q2.

Anything else to point out to folks as you look to maybe shift that SIC code to industrials or manufacturing versus chemicals

Competitive DynamicsTranscript · FY2025 Q2 →
Show response

Franzen pointed to portfolio composition (40% Healthcare & Water), stable performance vs volatile chemicals, and continued GICS reclassification work.

Calendar 2025 Q1

how should investors think about sort of the right companies to compare you with?

Competitive DynamicsM&ATranscript · FY2025 Q1 →
Show response

Kemp positioned Qnity as a semi-industry pure-play, acknowledging short-term multiple compression at peers but citing favorable long-term dynamics.

There's a lot of cost - a lot of questions on whether we peak, whether we're continuing to grow, what we're early in the potential

Cloud & AICapex InvestmentTranscript · FY2025 Q1 →
Show response

Kemp emphasized very early AI adoption innings, citing hyperscaler capex increases and Qnity's 15% data center exposure growing mid-teens.

Calendar 2024 Q4

Can you remind us how big, I guess, advanced nodes are now for semi-tech and Interconnect and then maybe what the growth rate for that subset will be in '25?

Cloud & AIRevenue GrowthTranscript · FY2024 Q4 →
Show response

Koch sized advanced nodes at ~40% of Semi portfolio with above-average growth, noting AI-specific exposure saw 30% growth.

organic growth in IndustrialsCo in the fourth quarter as well as your outlook in the first quarter, appears pretty differentiated relative to traditional chemical companies

Competitive DynamicsTranscript · FY2024 Q4 →
Show response

Koch highlighted growth profile, margin superiority, and lack of commodity pricing volatility vs chemicals. Breen noted Delrin divestiture removed last chemical vestige.

DOWDow Inc.6 questions · 6 reporting periods · 1 of 6 challenging
DOW company page →

Calendar 2026 Q1

When you think about the $1.75 billion for P&SP in 2Q, can you frame whether that is kind of a mid-cycle EBITDA or a peak EBITDA?

Show response

Carter said $0.26/lb integrated margin improvement is mid-cycle to slightly above. Impact is 3x Winter Storm Uri 2021. Expects environment to move from mid-cycle to peak levels. Recovery duration 6-18 months.

Calendar 2025 Q4

Can you help me understand how much of your ASP capacity goes to the export market?

DemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Fitterling said 30-40% to exports; product mix differentiation matters for returns. Long-term, Americas, Middle East and Argentina will be advantaged from gas cost position.

Calendar 2025 Q3

Can you bifurcate that from whether pricing or cost in the U.S., Europe and export?

Show response

Carter explained Q4 margin compression from feedstock costs not pricing, with $0.05/lb on table for October. Fitterling said 2026 improvement needs trade deal settlement; tech/AI/data centers will continue regardless.

Calendar 2025 Q2

How do you get adjusted EBIT better? It just seems like it could be a little bit better

Show response

Carter detailed Q3 margin improvement from June exit rate, July price increases, Poly-7 fully sold out. Fitterling described Diamond Infrastructure data center opportunity with 4,000-5,000 acres for colocation.

Calendar 2025 Q1

how could EBITDA get better in the second half? I know you have some cost savings

Show response

Fitterling cited three growth projects, normalizing energy costs, $300M cost reductions for the year, and supply chain flexing advantage. Wildcard is tariff clarity on demand.

Calendar 2024 Q4

if demand is unfortunately similar in 2025 versus 2024, I mean, directionally, should EBITDA be up, down, flat?

ChallengingMarginDemandTranscript · FY2024 Q4 →
Show response

Fitterling framed cost actions as the bridge to improved EBITDA, acknowledging pricing power is the real question rather than volume growth.

PPGPPG Industries6 questions · 6 reporting periods · 1 of 6 challenging
PPG company page →

Calendar 2026 Q1

how do you see volumes sort of shaping up sort of at the midpoint? Any effects from the [indiscernible] conflict on each of the segments?

DemandMacroeconomicTranscript · FY2026 Q1 →
Show response

Knavish outlined 5 H2 volume drivers: aerospace beating expectations with improving output, refinish recovering earlier than expected with 2 positive data points (claims and distributor orders), industrial share wins launching through year, Mexico retail strong with improving projects, packaging and PMC both growing. No order book changes from Iran conflict, only feedstock pricing impact. Morales reminded that H1 2025 refinish comps create much easier H2 comparisons.

Calendar 2025 Q4

Architectural EME, you know, a business that has struggled to grow. I mean, end markets, I understand. But, you know, why is that a good business?

ChallengingDemandMacroeconomicTranscript · FY2025 Q4 →
Show response

Knavish defended Architectural EMEA: generated record earnings and cash in 2023 (depressed market). Cash funds higher-growth businesses. Not projecting upside in 2026, assuming flat. Cost actions will drive margin and cash expansion. Morales noted COVID-era maintenance cycle pull-forward now reaching 5-year repaint window. Industrial more cyclical but seeing green shoots in Europe/LatAm share gains.

Calendar 2025 Q3

What do you think needs to happen for that business to sort of turn around maybe sometime next year?

DemandMacroeconomicTranscript · FY2025 Q3 →
Show response

Knavish identified France, Netherlands, U.K., and Poland as biggest markets. Consumer confidence driven by inflation, interest rates, wars, and energy. PPG taking aggressive structural cost actions, flat demand would deliver strong leverage due to 36 straight quarters of price increases. Eastern Europe recovering faster.

Calendar 2025 Q2

the only blemish looks like Refinish is down. All the other segments had a really nice year- over-year improvement. Just curious on the outlook for Refinish

DemandCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Knavish noted flat Refinish performance despite high-single-digit collision claim declines. Q3 expected soft due to distributor order pattern normalization, Q4 more normalized. Industry recovery of claims likely not until 2026. On PMC: 9 straight quarters of growth, bullish for foreseeable future driven by fire protection and marine aftermarket technologies.

Calendar 2025 Q1

Volumes pretty impressive there. What do you think your volume should be for this year in total? And then what do you think market demand is?

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Knavish highlighted strong demand across all Performance Coatings businesses. Morales added context on 2-year stacks: aerospace and PMC up double digits, refinish and traffic up low-to-mid single digits, with those traits expected to continue despite harder H2 comps.

Calendar 2024 Q4

Are there businesses you want to exit? Just maybe give us your thoughts on why -- what's last or what's in performance kind of Industrial Coatings

Capital AllocationM&ATranscript · FY2024 Q4 →
Show response

Knavish firmly stated no additional divestitures planned. Highlighted Performance Coatings 'crushed it' and Industrial at trough with significant volume leverage ahead.

SHWThe Sherwin-Williams Company6 questions · 6 reporting periods · 1 of 6 challenging
SHW company page →

Calendar 2026 Q1

it just feels like U.S. architectural paint demand in the U.S. has been structurally impaired

ChallengingDemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Heidi pushed back on word impaired, said under pressure. Assured scenario planning includes softer for much longer. Emphasized residential repaint as largest share gain opportunity even in this environment.

Calendar 2025 Q4

what do you think would be helpful in terms of maybe sparking a recovery in paint demand this year?

MacroeconomicRegulation PolicyDemandTranscript · FY2025 Q4 →
Show response

Heidi framed it as three-legged stool (income, rates, affordability) and pivoted to strong AI infrastructure/data center positioning for protective and marine.

Calendar 2025 Q3

Your pricing capture this year has been better or higher than in the past. What do you think pricing capture would be in '26

PricingCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Al declined to commit beyond 2026; emphasized balancing gallon growth with effectiveness; noted segment mix dilutes price/mix bucket reporting.

Calendar 2025 Q2

what mortgage rate do you think we need to get to for industry volumes to turn the corner? I mean, with six percent help, five percent

MacroeconomicDemandTranscript · FY2025 Q2 →
Show response

Heidi characterized sub-6% as meaningful trigger but equally cited consumer confidence and affordability. Jim noted Q2 new res up slightly vs double-digit completions declines as evidence of share gains.

Calendar 2025 Q1

price mix for the stores, up mid-single-digits. Was that mostly price or if it's maybe half-half with mix, what is that mix component to that equation?

PricingRevenue GrowthTranscript · FY2025 Q1 →
Show response

Al said mid-single-digit price mix was predominantly price with better effectiveness than last year; res repaint growth contributes positive mix shift vs commercial and property maintenance.

Calendar 2024 Q4

in 24, you generated pretty good APS growth of 10%. So if you think about '25

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Al walked through higher interest expense (refinancing at higher rates), new building financing, non-operating normalization, and ex-new-building midpoint of $12.15/~7% growth. Heidi added single-family starts and multi-family completions as persistent headwinds.

APDAir Products5 questions · 5 reporting periods · 1 of 5 challenging
APD company page →

Calendar 2026 Q1

There's a relatively sizable IPO coming at the summer in space. Just curious if you could give us your thoughts on your business in that sector

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Eduardo noted fast-growing segment with long NASA history since the 1960s. Working to increase share with commercial launches but declined specific financial details.

Calendar 2025 Q3

If you get to partners for sequestration pneumonia who want a similar return that you would want, is there still a good return on the hydrogen

Capex InvestmentMarginTranscript · FY2025 Q4 →
Show response

Eduardo confirmed APD viewing Louisiana as a standard hydrogen project that must meet normal return criteria for both sides. Believes room exists to reach right returns but capital cost estimate is key variable.

Calendar 2025 Q2

Have any update there? I haven't seen any announcements. How is bidding activity going with that?

Capex InvestmentDemandTranscript · FY2025 Q3 →
Show response

Eduardo noted strong pipeline of small projects and large electronics investments in Asia (Taiwan, China, Korea). Plans to summarize annual investment activity next quarter.

Calendar 2025 Q1

you think the $5 billion, would generate around a 5% or mid-single-digit return

ChallengingCapex InvestmentMarginTranscript · FY2025 Q2 →
Show response

Eduardo acknowledged the simplified math implies depreciation-only returns but wouldn't confirm specific hurdle rates for competitive reasons.

Calendar 2024 Q3

do you think at some point for the clean hydrogen projects that demand will be big enough? When you announce a project, you'll have offtakes immediately?

DemandCapex InvestmentTranscript · FY2024 Q4 →
Show response

Seifi committed to future projects requiring 50-60% offtake before announcement, modeling the traditional on-site business model.

IFFInternational Flavors & Fragrances5 questions · 5 reporting periods · 2 of 5 challenging
IFF company page →

Calendar 2026 Q1

At what point does this inflation flow through to the consumer and start to impact demand?

Show response

Erik expects continued solid demand. Fine Fragrance growth to moderate from double-digit but remain positive full year, with temporary Middle East import slowdown. Consumer Fragrance pipeline growing. Only commodity ingredients (~half of Fragrance Ingredient sales) remain challenged.

Calendar 2025 Q4

historically, International Flavors & Fragrances Inc. has slightly underperformed to F&F peers, but if you think about the portfolio going forward, the Health and Biosciences and Scent and Taste, h...

ChallengingCompetitive DynamicsInnovation & R&DTranscript · FY2025 Q4 →
Show response

Erik argued focused portfolio of Taste, Scent, H&B will accelerate growth through concentrated R&D investment and biotechnology cross-pollination. Cited EnviroCAPS and Super Carrot as examples of biotech-driven innovation across segments.

Calendar 2025 Q2

If you take out pharma from your first half EBITDA, it's somewhere around $1050 million. Your outlook for the second half implies mid-900s at the midpoint. It's about down 10% sequentially

ChallengingMarginDemandTranscript · FY2025 Q2 →
Show response

DeVeau attributed sequential EBITDA decline to normal Q4 seasonality (lowest margin quarter at ~17% last year vs 20%+ in H1) plus modest volume softening, though acknowledged he didn't have precise like-for-like comparison data available.

Calendar 2025 Q1

EBITDA margins first quarter were very good. And you guys talked about net pricing and productivity was noted for the year of increase. How much did each contribute

MarginCost PressureTranscript · FY2025 Q1 →
Show response

Erik attributed gains to productivity and mix improvement toward higher-margin products. Committed to above 15% EBITDA margin through 2026.

Calendar 2024 Q4

where do you think International Flavors & Fragrances Inc.'s EBITDA should get over time

Show response

Erik directly addressed long-term EBITDA margin target of low 20s and acknowledged food ingredients as the biggest challenge while expressing confidence in HNB, scent, and taste.

Show 5 more companies
LINLinde plc5 questions · 3 reporting periods · 3 of 5 challenging
LIN company page →

Calendar 2026 Q1

it's going to be what the third or fourth year of no economic improvement for industrial demand. I can't imagine the Iran conflict is going to help that

ChallengingMacroeconomicDemandTranscript · FY2026 Q1 →
Show response

White said stability needed for large durable goods and infrastructure projects requiring financing and long-range returns. IAA in Europe is a catalyst example. Americas showing positive signs from protectionist policies. APAC stable with China steady, India growing.

Chemicals and Energy, sales were up 3% in the first quarter on Slide 3. What do you think the run rate of that is heading into the 2Q

DemandRevenue GrowthTranscript · FY2026 Q1 →
Show response

White said Americas-led chemicals and energy strength expected to continue. Comps getting easier as they lap years of stagnant conditions. Remains positive on the outlook through the year.

Calendar 2025 Q3

you had commented that you saw the cycle will turn positive. We've seen a lot of companies this quarter have asset write-downs

ChallengingDemandMacroeconomicTranscript · FY2025 Q3 →
Show response

Sanjiv acknowledged chemicals most impacted currently. Cited European capacity rationalization as eventually supporting recovery. China chemicals still reasonable. Not suggesting imminent recovery but expects cycle to turn based on historical patterns.

SG&A was up 9% year-over-year, sequential up 3%. Any particularly -- any reason for that trend?

ChallengingCost PressureTranscript · FY2025 Q3 →
Show response

Sanjiv said quarterly SG&A has timing noise. Year-to-date SG&A up only 1%: M&A added ~1%, inflation ~2%, offset by restructuring savings of ~2%. Prefers YTD view over quarterly.

Calendar 2025 Q2

The recent agreement, it's a merchant contract, as I recall. So when do you think these will convert into an on-site?

DemandCapex InvestmentTranscript · FY2025 Q2 →
Show response

Sanjiv said space revenue quadrupled in 3 years. Supplies 4 out of 5 US launches. Investing ~$1B over next few years. Strong long-term customer commitments even if not classified as backlog.

LYBLyondellBasell4 questions · 4 reporting periods · 0 of 4 challenging
LYB company page →

Calendar 2026 Q1

can that product line turn positive? And you used to generate a good amount of EBITDA for polypropylene

PricingCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Peter emphasized PP as biggest upside opportunity. Market dynamics completely changed with US now seeing global demand for PP exports that normally stayed in production region. Kim noted PP operated at 70-75% for 2 years in Europe and US, meaning 15-20% operating rate improvement opportunity plus spread expansion. The longer the conflict persists, the better for PP.

Calendar 2025 Q4

how much of that capacity do you export

Competitive DynamicsPricingTranscript · FY2025 Q4 →
Show response

Peter noted LYB has historically lower exports due to more differentiated domestic portfolio. Kim quantified: LYB exported 34% and 38% in 2024/2025 vs industry ~48%. 2025 was difficult year for export pricing due to tariff-driven supply chain disruption. Expects 2026 normalization as tariffs and supply chains stabilize, improving netbacks across regions.

Calendar 2025 Q2

Do you think earnings could be up or down or just general direction given everything that you see now? And then longer term, I guess, mid-cycle potential for EBITDA, has it changed

Show response

Peter walked through segments: O&P Americas benefits from $85M less downtime plus improved PE margins and fixed cost reductions. Europe sees improved polymer margins with favorable naphtha and higher operating rates after Wesseling outage resolved. I&D expected flat. APS and Technology flat. Noted consumer behavior shifting toward more at-home consumption supporting packaging demand.

Calendar 2025 Q1

what trough EBITDA should be per se

Show response

Peter noted underlying Q1 EBITDA was ~$100M higher than Q4 when adjusting for $200M turnaround/weather impacts. Difficult to predict cycle bottom. Expects eventual durable goods replenishment but timing uncertain. Declined to give a specific trough number.

CFCF Industries3 questions · 2 reporting periods · 1 of 3 challenging
CF company page →

Calendar 2026 Q1

how tight do you think it will be? Do you think nitrogen and prevailing products will stay above the average, and how should we think about the longevity of this elevated pricing?

PricingSupply ChainTranscript · FY2026 Q1 →
Show response

Chris outlined extended recovery timeline: 30-40 day normal transport plus restart delays, vessel quality issues, inflation in risk premiums and insurance. Argued mid-cycle urea costs increase structurally. Bert compared disruption to running like a Ferrari now disrupted, with stocks-to-use ratios tight and Bangladesh, India, Pakistan facing suboptimal operations due to LNG dependency. Both expect pricing above average through 2027.

Calendar 2025 Q4

if it goes away, does that make it difficult or maybe impossible to get a premium price for Blue Point?

ChallengingRegulation PolicyPricingTranscript · FY2025 Q4 →
Show response

Chris argued CBAM removal would not eliminate premium opportunity due to broader ETS free allowance phase-out and growing global demand for low-carbon products. Bert confirmed contracts in place for 2026 with demand for more, seeing interest from industrial and agricultural customers globally beyond European regulation.

Is your bias that pricing kind of stays at this level and maybe the biases may be potentially to go up from here?

Show response

Bert said still room for prices to rise in North America but expects a correction in the back half as demand shifts from Northern to Southern Hemisphere planting. Cited 3-4 months of actual application demand in North America requiring 6-7 months of inventory build creating structural timing dynamics.

MOSMosaic Company (The)2 questions · 2 reporting periods · 0 of 2 challenging
MOS company page →

Calendar 2026 Q1

If the 2Q volumes come in as is, is that the base case for the third quarter

Show response

Bodine declined to confirm Q2 as Q3 base, citing scenarios ranging from rapid Persian Gulf resolution improving things within 60 days to protracted conflict requiring further curtailments. Sulfur availability, both price and physical access, is the key variable. Management cannot predict conflict resolution timeline. Additional curtailment options are being evaluated if needed.

Calendar 2025 Q4

If on Slide 14, the February '26 metrics don't change, is that a similar headwind for the rest of the quarters

MarginCost PressureTranscript · FY2025 Q4 →
Show response

Bodine noted sulfur headwind would persist if prices stay elevated but ammonia expected to decline through 2026. Improved turnaround costs and fixed cost absorption from higher production provide buffers. Luciano provided detailed breakeven math: Q4 realized $444/ton stripping margin, $108 EBITDA margin, normalized breakeven approximately $250/ton at full production. At $400 stripping margin, approximately $150/ton EBITDA achievable.

CTVACorteva1 question · 1 reporting period · 0 of 1 challenging
CTVA company page →

Calendar 2025 Q4

Anything in particular that gives you confidence there?

Show response

Robert said expecting modest global CP market growth in 2026, volume-driven with some pricing headwinds. Northern Hemisphere order books strong. Brazil has ample generic supply keeping pressure on pricing but differentiated products still in demand with 10-15% margin premium.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
DD DuPont110%none of 11 questions
DOW Dow Inc.617%1 of 6 questions
PPG PPG Industries617%1 of 6 questions
SHW The Sherwin-Williams Company617%1 of 6 questions
APD Air Products520%1 of 5 questions
IFF International Flavors & Fragrances540%2 of 5 questions
LIN Linde plc560%3 of 5 questions
LYB LyondellBasell40%none of 4 questions
CF CF Industries333%1 of 3 questions
MOS Mosaic Company (The)2—Rate withheld: fewer than 3 questions
  • DD
    DuPont · 11 questions
    0%none of 11 questions
  • DOW
    Dow Inc. · 6 questions
    17%1 of 6 questions
  • PPG
    PPG Industries · 6 questions
    17%1 of 6 questions
  • SHW
    The Sherwin-Williams Company · 6 questions
    17%1 of 6 questions
  • APD
    Air Products · 5 questions
    20%1 of 5 questions
  • IFF
    International Flavors & Fragrances · 5 questions
    40%2 of 5 questions
  • LIN
    Linde plc · 5 questions
    60%3 of 5 questions
  • LYB
    LyondellBasell · 4 questions
    0%none of 4 questions
  • CF
    CF Industries · 3 questions
    33%1 of 3 questions
  • MOS
    Mosaic Company (The) · 2 questions
    —rate withheld: under 3 questions
Show all 11 companies
CompanyQuestionsChallenge rate
CTVA Corteva1—Rate withheld: fewer than 3 questions
  • CTVA
    Corteva · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q310%none of 1 question1
2024 Q4617%1 of 6 questions5
2025 Q1813%1 of 8 questions7
2025 Q2911%1 of 9 questions8
2025 Q3729%2 of 7 questions6
2025 Q41127%3 of 11 questions9
2026 Q11217%2 of 12 questions10
  1. 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2024 Q46 questions · challenge rate 17% (1 of 6 questions) · 5 companies
  3. 2025 Q18 questions · challenge rate 13% (1 of 8 questions) · 7 companies
  4. 2025 Q29 questions · challenge rate 11% (1 of 9 questions) · 8 companies
  5. 2025 Q37 questions · challenge rate 29% (2 of 7 questions) · 6 companies
  6. 2025 Q411 questions · challenge rate 27% (3 of 11 questions) · 9 companies
  7. 2026 Q112 questions · challenge rate 17% (2 of 12 questions) · 10 companies

Topics

Topics tagged on this analyst’s questions.

  • Demand27
  • Competitive Dynamics14
  • Margin14
  • Pricing10
  • Macroeconomic9
  • Revenue Growth6
  • Capex Investment6
  • Cost Pressure5
  • Cloud & AI3
  • M&A3
Show all 14 topics
  • Supply Chain2
  • Regulation Policy2
  • Innovation & R&D1
  • Capital Allocation1